Scynexis (SCYX) Interest Coverage Ratio (2013 - 2026)
Scynexis' (SCYX) quarterly Interest Coverage Ratio came in at 677.56 in Q1 2026, down 3205.17% YoY from 21.82 in Q1 2025, and down 2186.58% on a QoQ basis from 32.47 in Q4 2025.
Scynexis (SCYX) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Interest Coverage Ratio data on file, last reported at 677.56 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 3205.17% year-over-year to 677.56 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 975.36 (down 3303.8% YoY) and the FY2025 annual result came in at 21.6, down 3891.57% from the prior year.
- Interest Coverage Ratio declined to 677.56 in Q1 2026, from 32.47 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 195.47 in Q4 2023 to a low of 1681.0 in Q3 2025.
- A 5-year average of 143.86 and a median of 19.23 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio surged 2631.88% — and 2025, when it slumped 3369.51%.
- Tracing SCYX's Interest Coverage Ratio over 5 years: stood at 7.15 in 2022, then surged by 2631.88% to 195.47 in 2023, then tumbled by 119.53% to 38.17 in 2024, then soared by 185.08% to 32.47 in 2025, then sank by 2186.58% to 677.56 in 2026.
- The last three Interest Coverage Ratio figures came in at 677.56 (Q1 2026), 32.47 (Q4 2025), and 1681.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -677.56 |
| Dec 31, 2025 | 32.47 |
| Sep 30, 2025 | -1,681.00 |
| Mar 31, 2025 | -20.50 |
| Dec 31, 2024 | -38.17 |
| Sep 30, 2024 | -48.45 |
| Jun 30, 2024 | -36.37 |
| Mar 31, 2024 | -22.64 |
| Dec 31, 2023 | 195.47 |
| Sep 30, 2023 | -47.63 |
| Jun 30, 2023 | 93.29 |
| Mar 31, 2023 | -6.44 |
| Dec 31, 2022 | 7.15 |
| Sep 30, 2022 | -15.81 |
| Jun 30, 2022 | -17.66 |
| Mar 31, 2022 | -17.96 |
| Dec 31, 2021 | -32.50 |
| Sep 30, 2021 | -19.08 |
| Jun 30, 2021 | -39.34 |
| Mar 31, 2021 | -3.80 |